{"entity":{"type":"insider","cik":"0001691218","url":"/insider/0001691218","json_url":"/insider/0001691218.json","name":"Furey John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2018-01-22","last":"2018-04-24","span_basis":"filed_date"},"name_variants":[{"name":"Furey John","source":"filing","n_filings":4,"first_seen":"2018-01-22","last_seen":"2018-04-24"}],"transactions":[{"id":5979153,"accession":"0001609351-18-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-18-000038","line_url":"/filing/0001609351-18-000038#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001691218","owner_name":"Furey John","owner_display_name":"Furey John","owner_url":"/insider/0001691218","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6723.0,"shares_display":"6,723","price_per_share":82.5,"price_display":"82.50","price_state":"stated","total_value":554647.5,"total_display":"554,647.50","total_whole":"554,648","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-20","filed_date":"2018-04-24","scope":"insider"},{"id":6103990,"accession":"0001609351-18-000032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001609351-18-000032","line_url":"/filing/0001609351-18-000032#line-4","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001691218","owner_name":"Furey John","owner_display_name":"Furey John","owner_url":"/insider/0001691218","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":82.53,"price_display":"82.53","price_state":"stated","total_value":907830.0,"total_display":"907,830.00","total_whole":"907,830","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-18","filed_date":"2018-04-19","scope":"insider"},{"id":6103984,"accession":"0001609351-18-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-18-000032","line_url":"/filing/0001609351-18-000032#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001691218","owner_name":"Furey John","owner_display_name":"Furey John","owner_url":"/insider/0001691218","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2277.0,"shares_display":"2,277","price_per_share":82.5,"price_display":"82.50","price_state":"stated","total_value":187852.5,"total_display":"187,852.50","total_whole":"187,853","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-17","filed_date":"2018-04-19","scope":"insider"},{"id":6319035,"accession":"0001609351-18-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-18-000030","line_url":"/filing/0001609351-18-000030#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001691218","owner_name":"Furey John","owner_display_name":"Furey John","owner_url":"/insider/0001691218","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":77.51,"price_display":"77.51","price_state":"stated","total_value":1550200.0,"total_display":"1,550,200.00","total_whole":"1,550,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-12","filed_date":"2018-04-16","scope":"insider"},{"id":6798969,"accession":"0001609351-18-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-18-000009","line_url":"/filing/0001609351-18-000009#line-2","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001691218","owner_name":"Furey John","owner_display_name":"Furey John","owner_url":"/insider/0001691218","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18.0,"shares_display":"18","price_per_share":46.33,"price_display":"46.33","price_state":"stated","total_value":833.94,"total_display":"833.94","total_whole":"834","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-11","filed_date":"2018-01-22","scope":"insider"},{"id":6798965,"accession":"0001609351-18-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001609351-18-000009","line_url":"/filing/0001609351-18-000009#line-1","is_derivative":false,"issuer_cik":"0001609351","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001609351","owner_cik":"0001691218","owner_name":"Furey John","owner_display_name":"Furey John","owner_url":"/insider/0001691218","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18.0,"shares_display":"18","price_per_share":73.48,"price_display":"73.48","price_state":"stated","total_value":1322.64,"total_display":"1,322.64","total_whole":"1,323","shares_owned_after":18.0,"shares_owned_after_display":"18","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-08","filed_date":"2018-01-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001609351","name":"Spark Therapeutics, Inc.","url":"/issuer/0001609351","role":"Officer (Chief Operating Officer)","n_filings":4,"first_seen":"2018-01-22","last_seen":"2018-04-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001691218","retrieved_at":"2026-08-27T14:46:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}